Education
About Us
Working with TipRanks
Follow Us
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 31.25M | $ 29.75M | $ 6.76M | $ 6.48M | $ 4.23M |
| Gross Profit | $ 13.17M | $ 17.79M | $ 2.05M | $ 1.35M | $ 172.00K |
| Operating Income | $ -97.36M | $ -85.15M | $ -65.38M | $ -50.91M | $ -111.06M |
| EBITDA | $ -117.56M | $ -84.36M | $ -65.06M | $ -48.20M | $ -90.84M |
| Net Income | $ -88.48M | $ -88.66M | $ -114.28M | $ -51.15M | $ -142.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 119.11M | $ 229.81M | $ 225.66M | $ 54.13M | $ 75.02M |
| Total Assets | $ 197.41M | $ 254.60M | $ 251.21M | $ 70.78M | $ 98.30M |
| Total Debt | $ 426.00K | $ 684.00K | $ 693.00K | $ 11.26M | $ 637.00K |
| Net Debt | $ -39.45M | $ -44.59M | $ -26.66M | $ -42.88M | $ -35.30M |
| Total Liabilities | $ 40.23M | $ 56.98M | $ 53.87M | $ 33.13M | $ 28.39M |
| Stockholders' Equity | $ 157.18M | $ 197.62M | $ 197.34M | $ 37.65M | $ 69.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -79.63M | $ -68.17M | $ -52.44M | $ -39.09M | $ -98.06M |
| Operating Cash Flow | $ -78.33M | $ -67.57M | $ -52.13M | $ -38.63M | $ -96.44M |
| Investing Cash Flow | $ 46.22M | $ 12.63M | $ -167.63M | $ 6.39M | $ 105.68M |
| Financing Cash Flow | $ 26.71M | $ 72.87M | $ 225.05M | $ 18.37M | $ -30.32M |